Market Access Strategy
Market access for pharmaceuticals, biotechnology products, diagnostics and medical devices is becoming increasingly restricted, with mandatory price cuts, restrictions placed on prescribing freedom, health technology assessments, budget processes, formularies and the professionalisation of procurement.
Strategically, market access is about packaging data in the right way, for the right customer at the right time.
Bridgehead ’s expertise and experience in market access strategy development and implementation can help you to achieve this through:
- Considering the implications your product may have on the wider healthcare market
- Understanding the impact the changing healthcare market will have on your product
- Preparing a positive healthcare environment which supports uptake of your product
- Communicating the “value” of your product to the range of customers who influence uptake
- Therapy area environmental scanning
Bridgehead provides a comprehensive range of market access strategy support services:
- Pricing assessment and strategy
- Payer research
- KOL, physician and patient research
- Health economic assessment and modelling
- Reimbursement negotiation strategy
- Preparation of core reimbursement dossiers
- Development and testing of value propositions and messaging
- Product lifecycle and portfolio strategy
- Pricing, reimbursement and market access due diligence
For further information please contact us now.
